The incidence of atrial fibrillation post-cardiac surgery is estimated to be around 30%-40%. 1 Atrial fibrillation post-cardiac surgery, being associated with increased morbidity and mortality, is also associated with increased utilization of medical resources and surged health-care cost. Consequently, there has been a quest toward the need for an ideal and noninvasive method for the prevention of atrial fibrillation post-cardiac surgery. Drugs like beta blockers have been studied and scrutinized for prevention of atrial fibrillation post-cardiac surgery with commendatory results. 2 Remote ischemic preconditioning technique has recently gained popularity as a method to prevent ischemic reperfusion injury during cardiac surgery. The technique consists of inducing brief episodes of ischemia followed by reperfusion in a remote vascular territory or an organ. The technique has also been studied to prevent acute kidney injury following cardiac surgery. 3 However, the evidence regarding the effect of remote ischemic preconditioning on the risk of atrial fibrillation post-cardiac surgery is controversial.
fibrillation (NOAF) post-cardiac surgery. Therefore, we performed an updated meta-analysis of randomized control trials by comparing remote ischemic preconditioning with controls and the outcome of interest was NOAF, for pooled estimation in meta-analysis.
| ME THODS
The systemic review was performed in accordance with the PRISMA (Preferred reporting items for systemic review) and AHA (American heart association) guidelines. 4, 5 We performed a systematic search through PubMed database to identify relevant randomized control trials from inception to July 2019. The following terms were used for systematic search in the PubMed database-"remote ischemic pre-condition*, "remote ischemic precondition*", "cardiac surgery", "bypass-surgery", "bypass", "surgical aortic valve replacement", SAVR. The search strategy is further elaborated in the supplementary file. The inclusion criteria for studies were: randomized control trials studying the effect of remote ischemic preconditioning juxtaposed to controls in subjects undergoing cardiac surgery and reporting the incidence of NOAF. Articles were not excluded based on sample size. Only manuscripts published in English were considered for final analysis. The database search was augmented with manual search of bibliographies of included articles, to include relevant articles not identified by database search. The PRISMA flow chart for inclusion of studies is depicted in Figure 1 .
Two authors AK and MS independently screened the abstracts to include relevant articles and performed data extraction. Any disparity was resolved by mutual consensus. Data extraction was performed in accordance with a standardized predefined data extraction form. The following data were extracted from each study: author's name, year of study, study design, number randomized, mean age, percentage male, primary outcomes of interest, number of individuals with NOAF in the intervention and control group.
We used Mantel-Haenzsel method with random error model to calculate risk ratio (RR) with 95% confidence interval (CI).
Heterogeneity was assessed using the I 2 test > 50% or χ 2 P < .05.
Publication bias was visually assessed using funnel plot. The analysis was carried out using RevMan Version 5.3. (Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014).
| RE SULTS
The systematic search unveiled a total of 171 eligible articles.
Twelve randomized control trials were included in the final analysis. 3, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] This sums up to a total of 2652 procedures in the remote ischemic preconditioning group and 2667 procedure in the control group. There were three prominent studies of the 12 included studies, 10, 14, 16 which together constituted more than 75% of the patients in the final analysis. Baseline characteristics of included studies are shown in Table 1 . The exact technique of remote ischemic preconditioning used in each included trial has also been outlined in Table 1 . Of the 12 randomized control trials included, only eight trials randomized patients undergoing coronary artery Full-text arƟcles assessed for eligibility (n = 18)
Full-text arƟcles excluded, with reasons (n = 6)
Five studies did not report atrial fibrillaƟon in the clinical outcome.
One study reported arrhythmia post-op, without the specifics of type of arrhythmia and hence excluded.
Studies included in qualitaƟve synthesis
(n = 12)
Studies included in quanƟtaƟve synthesis
(meta-analysis) (n = 12) (Table S1 ).
TA B L E 1 Baseline characteristics of included studies
Remote ischemic preconditioning did not alter the risk of NOAF post-cardiac surgery [RR: 0.95, CI: 0.83-1.09, P = .48, I 2 = 37%, χ 2 P = .09] (Figure 2 ). There was no heterogeneity associated with the pooled estimate as evident from the I 2 and χ 2 P-value. Visual inspection of the funnel plot did not depict publication bias ( Figure S1 ).
| D ISCUSS I ON
An updated meta-analysis comparing remote ischemic preconditioning with controls using the data from 12 randomized control trials with 2652 procedures in the intervention arm and 2667 procedures in the control arm was performed. The main result of this meta-analysis concluded that remote ischemic preconditioning prior to cardiac surgery did not curtail the risk of NOAF. To our knowledge, this was the first meta-analysis researching the effect of remote ischemic preconditioning on NOAF, prior to cardiac surgery.
A study by Krogstad et al had similar conclusion as our metaanalysis which found no difference in the incidence of NOAF among the remote ischemic precondition group as compared to the control group undergoing cardiac surgery. 15 Besides, the three large trials, studying the effect of remote ischemic preconditioning on clinical outcomes in patients undergoing cardiac surgery, namely the RIPHeart trail, the ERICCA trial, and the study by Hong et al, found no beneficial effect of remote ischemic preconditioning on the incidence of NOAF post-surgery. 10, 14, 16 The results of this meta-analysis are however incongruous with the results of a randomized control trial which concluded that remote ischemic preconditioning reduced the inducibility and sustainability of nonvalvular atrial fibrillation. Additionally, the study also concluded that these changes were possibly mediated by alteration in the electrophysiological properties of the atria. 17 In a study by Candilio et al, remote ischemic precondition significantly reduced the incidence of NOAF among subjects undergoing cardiac surgery. 6 Furthermore, Candilio et al also concluded that remote ischemic preconditioning reduced perioperative myocardial injury in patients undergoing cardiac surgery, which could have contributed to the reduced incidence of NOAF. Supporting the previous study was a study by Slagsvold et al, which concluded that remote ischemic preconditioning minimized the incidence of NOAF among subjects undergoing coronary artery bypass graft. The study further concluded that this reduction in incidence of NOAF can be accredited to preserved mitochondrial function by remote ischemic preconditioning and its influence on myocardial MicroRNA (miR) expression of the atrial myocardium among subjects undergoing coronary artery bypass surgery. 9 The study adumbrated regarding the prevention of miR upregulation by remote ischemic preconditioning prior to cardiac surgery. Increased miR expression has been associated with greater extent of myocardial injury following ischemia reperfusion injury. 18 Finally, the method used for inducing remote ischemic preconditioning varied slightly in each trial and has not been attributed in the present analysis.
In conclusion, the present meta-analysis of randomized control trials did not delineate any beneficial effect of remote ischemic preconditioning on the risk of NOAF.
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